Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ghanem, US

Ayman Mohammad Ghanem, Colorado Springs, CO US

Patent application numberDescriptionPublished
20100325480FAILOVER CONTROL OF DUAL CONTROLLERS IN A REDUNDANT DATA STORAGE SYSTEM - A redundant data storage system is provided comprising a first controller with top-level control of a first memory space and a second controller with top-level control of a second memory space different than the first memory space. The system is adapted for asynchronously reflectively writing state information by the first controller to the second memory space; alternatively the system is adapted for asynchronously reflectively writing state information by the second controller to the first memory space. A method is provided for operating the redundant data storage system by resolving any inconsistency between the existing state information and a modified state information associated with a state information change request, and for switching control in the redundant data storage system between the controllers.12-23-2010

Bernard Ghanem, Champaign, IL US

Patent application numberDescriptionPublished
20110142335Image Comparison System and Method - An image comparison system includes a memory unit that stores data representative of target apparel images that depict apparel items. An image processing unit is provided to process a query apparel image to extract data representative of a query apparel item depicted in the query apparel image. The image processing unit determines weighted color and pattern differences between the target apparel images and the query apparel image.06-16-2011

Bernard S. Ghanem, Champaign, IL US

Patent application numberDescriptionPublished
20090034816Reduction of Lymph Tissue False Positives in Pulmonary Embolism Detection - A system for automatically detecting pulmonary emboli from medical image data includes receiving image data, automatically detecting one or more pulmonary embolism candidates from the image data, segmenting an airway tract from the image data, segmenting an artery structure from the image data, calculating a distance between each of the candidates and a nearest portion of the segmented airway, determining whether each of the candidates is within or outside of the segmented artery structure, rejecting candidates based on the calculated distance between each of the candidates and the nearest portion of the segmented airway and the determination as to whether each of the candidates is within or outside of the segmented artery structure, and indicating the location of the non-rejected candidates within the image data.02-05-2009
20090060307Tensor Voting System and Method - Described herein is a method and system for facilitating a tensor voting scheme. The tensor voting scheme includes determining at least one voter point and at least one receiver point from input data and determining a tensor vote directed from the receiver point to the voter point.03-05-2009

Eman Ghanem, Austin, TX US

Patent application numberDescriptionPublished
20120009630STABILIZED REVERSE TRANSCRIPTASE FUSION PROTEINS - Stabilized reverse transcriptase fusion proteins including a thermostable reverse transcriptase connected to a stabilizer protein are described. Attaching the stabilizer protein to the thermostable reverse transcriptase stabilizes the fusion protein and can aid in its purification, provide increased solubility, allow for longer storage, or allow the fusion protein to be used under more rigorous conditions such as higher temperature. The stabilized reverse transcriptase fusion protein can also include a linker between the stabilizer protein and the thermostable reverse transcriptase. The stabilized reverse transcriptase fusion proteins are suitable for use in nucleic acid amplification methods such as the reverse transcription polymerase chain reaction and other applications involving cDNA synthesis.01-12-2012

George Ghanem, Redmond, WA US

Patent application numberDescriptionPublished
20110153809Legal Intercept - Aspects of the subject matter described herein relate to silently recording communications. In aspects, data associated with a request to establish a communication is modified to cause the communication to be established via a path that includes a recording agent. Modification may include, for example, adding, changing, and/or deleting data within the data. The data as modified is then passed to a protocol entity that uses the data to establish a communication session. Because of the way in which the data has been modified, the protocol entity selects a path that includes the recording agent. The recording agent is then able to silently record the communication.06-23-2011

Marilyn Ghanem, St. Louis, MO US

Patent application numberDescriptionPublished
20080255001Screening of chemical compounds purified from biological sources - A method of producing a chemical compound library comprises extracting at least one extract from at least one species of plant; processing at least one of the extract(s) to remove at least one type of chemical interference to produce a processed extract; chromatographically separating the processed extract into a plurality of chromatographic fractions, each containing an amount of chemical compounds; determining the amount of chemical compounds in at least one of the chromatographic fractions; and normalizing the chromatographic fractions in which the amounts were determined to produce normalized chromatographic fractions, each such fraction comprising from about 1 microgram to about 500 micrograms of each of from one to seven chemical compounds that were present in lower concentrations in the extract and that each have a log P of from about −1 to about 5 and a molecular weight less than about 1000 Daltons; thereby to produce a chemical compound library from at least one species of plant.10-16-2008
20080280770METHOD OF ISOLATING BIOLOGICALLY ACTIVE CHEMICAL COMPOUNDS FROM A CHEMICAL COMPOUND LIBRARY - A method of producing a chemical compound library comprises extracting at least one extract from at least one species of plant; processing at least one of the extract(s) to remove at least one type of chemical interference to produce a processed extract; chromatographically separating the processed extract into a plurality of chromatographic fractions, each containing an amount of chemical compounds; determining the amount of chemical compounds in at least one of the chromatographic fractions; and normalizing the chromatographic fractions in which the amounts were determined to produce normalized chromatographic fractions, each such fraction comprising from about 1 microgram to about 500 micrograms of each of from one to seven chemical compounds that were present in lower concentrations in the extract and that each have a log P of from about −1 to about 5 and a molecular weight less than about 1000 Daltons; thereby to produce a chemical compound library from at least one species of plant.11-13-2008

Raja N. Ghanem, Edina, MN US

Patent application numberDescriptionPublished
20080275516METHOD AND APPARATUS FOR DETECTING ARRHYTHMIAS IN A MEDICAL DEVICE - A method and apparatus of updating a sensing parameter in a medical device that includes sensing cardiac signals, determining intervals in response to the sensed cardiac signals, determining interval patterns associated with the determined intervals, and updating the sensing parameter in response to the determined interval patterns.11-06-2008
20080275517METHOD AND APPARATUS FOR DETECTING ARRHYTHMIAS IN A MEDICAL DEVICE - A method and apparatus for determining oversensing in a medical device that includes sensing cardiac signals, determining an oversensing characteristic associated with cardiac signals sensed during a predetermined sensing window, identifying oversensing in response to the oversensing characteristic, determining, in response to oversensing being identified, an adjusting characteristic associated with cardiac signals sensed during the predetermined sensing window, and updating a sensing parameter in response to the determined adjusting characteristic.11-06-2008
20080275518METHOD AND APPARATUS FOR DETECTING ARRHYTHMIAS IN A MEDICAL DEVICE - A method and apparatus for determining oversensing of cardiac signals that includes a housing containing electronic circuitry, an electrode coupled to the electronic circuitry to sense cardiac signals, and a processor, positioned within the housing, to determine an oversensing characteristic associated with the cardiac signals sensed over a predetermined sensing window, and to identify oversensing in response to the determined oversensing characteristic.11-06-2008
20080275519METHOD AND APPARATUS FOR DETECTING ARRHYTHMIAS IN A MEDICAL DEVICE - A method and apparatus for adjusting a sensing parameter in a medical device that includes a sensing electrode sensing cardiac signals, a processor to determine an adjusting characteristic associated with the cardiac signals sensed over a predetermined sensing window, and a control unit to update the sensing parameter in response to the determined adjusting characteristic.11-06-2008
20100030093PERIODIC BEAT DETECTION TO DETECT ARTIFACTS IN A CARDIAC ELECTROGRAM - Techniques for determining whether artifacts are present in a cardiac electrogram are described. According to one example, a medical device senses a cardiac electrogram via electrodes. The medical device determines a derivative, e.g., a second order derivative, the electrogram. The medical device detects beats within the derivative, e.g., by comparing a rectified version of the derivative to one or more thresholds determined based on a maximum of the rectified derivative. The medical device determines whether the beats are periodic, and determines whether artifacts are present in the cardiac electrogram based on the determination of whether the beats are periodic. The medical device may further determine whether tachyarrhythmia is present and/or whether the cardiac rhythm of the patient is treatable based on the determination of whether the beats are periodic. For example, the medical device may determine that an electrogram is not treatable when the beats are periodic.02-04-2010
20100113889CARDIAC RISK STRATIFICATION UTILIZING BAROREFLEX SENSITIVITY MEASUREMENT - A monitoring or therapy system may obtain a baroreflex sensitivity (BRS) measurement via an implantable medical device (IMD). The monitoring or therapy system then may generate a risk stratification indicator based on the BRS measurement. In some examples, the IMD generates the risk stratification indicator, while in other examples, an external computing device, such as a programmer, generates the risk stratification indicator. The monitoring or therapy system also may obtain at least one of a heart rate variability (HRV) measurement and a non-sustained ventricular tachycardia (NSVT) indicator via the IMD, and may generate the risk stratification indicator based on the BRS measurement and one or both of the HRV measurement and the NSVT indicator. In some examples, the monitoring or therapy system may generate an instruction, indicator, or alert based on the risk stratification indicator. The indicator may indicate that the patient is a candidate for an implantable therapy device.05-06-2010
20100204597METHOD AND APPARATUS FOR DETECTING ARRHYTHMIAS IN A MEDICAL DEVICE - A method of detecting a cardiac event that includes sensing cardiac signals from a plurality of electrodes, determining rates of change of the sensed cardiac signals, and determining a range of the sensed cardiac signals. The sensed cardiac signals are detected as being associated with the cardiac event in response to the determined rates of change and the determined range.08-12-2010
20110137193CONTINUOUS MONITORING OF RISK BURDEN FOR SUDDEN CARDIAC DEATH RISK STRATIFICATION - System and method for assessing a likelihood of a patient to experience a cardiac arrhythmia. A biological sensor is configured to sense biological parameters of the patient. A processor is coupled to the biological sensor and is configured to determine the likelihood of the patient experiencing a cardiac arrhythmia based, at least in part, on a combination of the biological parameters, the combination dynamically weighting each of the plurality of biological parameters based on another one of the plurality of biological parameters.06-09-2011
20110245700DETECTION OF T-WAVE ALTERNANS PHASE REVERSAL FOR ARRHYTHMIA PREDICTION AND SUDDEN CARDIAC DEATH RISK STRATIFICATION - An implantable medical device and associated method for classifying a patient's risk for arrhythmias by sensing a cardiac electrogram (EGM) signal and selecting a first pair of T-wave signals and a second pair of T-wave signals. A first difference between the two T-wave signals of the first pair is compared to a second difference between the two T-wave signals of the second pair. A T-wave alternans phase reversal is detected in response to comparing the first difference and the second difference, and the patient's arrhythmia risk is classified in response to detecting the phase reversal.10-06-2011
20110301479System and Method for Assessing a Likelihood of a Patient to Experience a Future Cardiac Arrhythmia Using Dynamic Changes in a Biological Parameter - System and method for assessing a likelihood of a patient to experience a cardiac arrhythmia using dynamic changes in a biological parameter. A biological sensor is configured to sense a biological parameter of the patient. A processor is coupled to the biological sensor and is configured to determine a dynamic change of the biological parameter and determine the likelihood of the patient experiencing a cardiac arrhythmia based, at least in part, on the dynamic change of the biological parameter.12-08-2011
20110301480SYSTEM AND METHOD FOR ASSESSING A LIKELIHOOD OF A PATIENT TO EXPERIENCE A CARDIAC ARRHYTHMIA - Systems and method for assessing a likelihood of a patient having a heart to experience a cardiac arrhythmia. A sensor is configured to detect a premature ventricular contraction of the heart, the premature ventricular contraction being premature relative to a rate of ventricular contractions during a period preceding the premature ventricular contraction. A processor is configured to determine a dispersion of a predetermined number of repolarizations of the heart of the patient occurring following the premature ventricular contraction of the heart if a compensatory pause is detected in conjunction with the premature ventricular contraction, then determine the likelihood of the patient experiencing the cardiac arrhythmia based, at least in part, on the dispersion of the plurality of repolarizations of the heart of the patient.12-08-2011

Patent applications by Raja N. Ghanem, Edina, MN US